Gastrointestinal Disbiyosis ve Hastalıklarla Etiyolojik İlişkisi

Aksu D, Aksu B. İnsan Mikrobiyotası. Eskişehir Teknik Üniversitesi Bilim ve Teknoloji Dergisi - C Yaşam Bilimleri Ve Biyoteknoloji. 2020;9(1). doi: 10.18036/estubtdc.515976

Yüksel Altuntaş D, Batman A. Mikrobiyota ve metabolik sendrom. Türk Kardiyoloji Derneği Arşivi. 2017;45(3):286-96. doi: 10.5543/tkda.2016.72461

Nacar G, TİMUR S. Kadın Sağlığı ve Mikrobiyota. Kadın Sağlığı Hemşireliği Dergisi.7(1):48-70

Nikoletopoulou V, Kyriakakis E, Tavernarakis N. Cellular and molecular longevity pathways: the old and the new. Trends in Endocrinology and Metabolism. 2014;25(4) doi: 10.1016/j.tem.2013.12.003

Pelzer E, Gomez-Arango LF, Barrett HL, et al. Review: Maternal health and the placental microbiome. Placenta. 2017;54:30-7. doi: 10.1016/j.placenta.2016.12.003

Ottman N, Smidt H, De Vos WM, et al. The function of our microbiota: who is out there and what do they do? Frontiers in cellular and infection microbiology. 2012;2:104. doi: 10.3389/fcimb.2012.00104

von Martels JZ, Sadabad MS, Bourgonje AR, et al. The role of gut microbiota in health and disease: In vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut. Anaerobe. 2017;44:3-12. doi: 10.1016/j.anaerobe.2017.01.001

Alkan ŞŞ. İmmün sistem ve barsak mikrobiyotası. Journal of Biotechnology and Strategic Health Research. 2017;1:7-16

Evrensel A, Ceylan ME. Bağırsak beyin ekseni: Psikiyatrik bozukluklarda bağırsak mikrobiyotasının rolü. Psikiyatride güncel yaklaşımlar. 2015;7(4):461-72

Çimen F, Polat H, Ekici L. Polifenollerin Bağırsak Mikrobiyota Kompozisyonunu Düzenleyici ve Nöroprotektif Etkileri. Akademik Gıda. 2020;18(2):190-208. doi: 10.24323/akademik-gida.758838.

Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Medicine. 2016;8(1):51. doi: 10.1186/s13073-016-0307-y

Aslan NYH. Anne sütü ve mikrobiyota. Türkiye Klinikleri Beslenme ve Diyetetik. 2017;3(2):95-100

Özden A. Sağlıklı Yaşam İçin Yararlı Dost Bakteriler. Türk Gastroentoloji Vakfı Yayınları, Ankara. 2006

Gomez-Gallego C, Garcia-Mantrana I, Salminen S, et al., editors. The human milk microbiome and factors influencing its composition and activity. Seminars in Fetal and Neonatal Medicine; 2016 21(6):400-405. doi: 10.1016/j.siny.2016.05.003.

Gevers D, Knight R, Petrosino JF, et al. The Human Microbiome Project: a community resource for the healthy human microbiome. PLoS Biology. 2012;10(8):e1001377.doi:10.1371/journal.pbio.1001377

Lander ES. Initial sequencing and analysis of the human germane. Nature. 2001;409:860-921 doi: 10.1038/35057062

Schwartz S, Friedberg I, Ivanov IV, et al. A metagenomic study of diet-dependent interaction between gut microbiota and host in infants reveals differences in immune response. Genome Biology. 2012;13(4):r32.doi:10.1186/gb-2012-13-4-r32

Carding S, Verbeke K, Vipond DT, et al. Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health Disease. 2015;26(1):26191. doi: 10.3402/mehd.v26.26191.

Toor D, Wsson MK, Kumar P, et al. Dysbiosis Disrupts Gut Immune Homeostasis and Promotes Gastric Diseases. International Journal of Molecular Sciences. 2019;20(10):2432. doi:10.3390/ijms20102432

Iizasa H, Ishihara S, Richardo T, et al. Dysbiotic infection in the stomach. World Journal of Gastroenterology 2015;21(40):11450-7. doi:10.3748/wjg.v21.i40.11450

Lobionda S, Sittipo P, Kwon HY, et al. The Role of Gut Microbiota in Intestinal Inflammation with Respect to Diet and Extrinsic Stressors. Microorganisms. 2019;7(8):271. doi:10.3390/microorganisms7080271

Martinez KB, Leone V, Chang EB. Western diets, gut dysbiosis, and metabolic diseases: Are they linked? Gut microbes. 2017;8(2):130-42 doi: 10.1080/19490976.2016.1270811

Sanlier N, Kocabas Ş. The effect of probiotic, prebiotic and gut microbiota on ASD: A review and future perspectives. Critical Reviews in Food Science and Nutrition 2021;6(1):12. doi: 10.1080/10408398.2021.1973957.

Imhann F, Vich Vila A, Bonder MJ, et al. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota. Gut Microbes. 2017;8(4):351-8. doi: 10.1080/19490976.2017.1284732

Lange K, Buerger M, Stallmach A, et al. Effects of Antibiotics on Gut Microbiota. Digestive Diseases. 2016;34(3):260-8. doi:10.1159/000443360

Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. The New England Journal of Medicine. 2016;375(24):2369-79. doi:10.1056/NEJMra1600266

Duboc H, Rainteau D, Rajca S, et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterology and Motilite. 2012;24(6):513-20, e246-7. doi:10.1111/j.1365-2982.2012.01893.x

Thomas KR, Watt J, Wu CMJ, et al. Pain and Opioid-Induced Gut Microbial Dysbiosis. Biomedicines. 2022;10(8):1815. doi:10.3390/biomedicines10081815

Kartalcı Ş. Şizofreni Etyolojisinde Mikrobiyotanın Rolü. Psikiyatride Güncel Yaklaşımlar. 2018;10(2):265-78. doi:10.18863/pgy.358105

Meyer U, Feldon J, Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatric research. 2011;69(8):26-33. doi: 10.1203/PDR.0b013e318212c196

Dinan TG, Borre YE, Cryan JF. Genomics of schizophrenia: time to consider the gut microbiome? Molecular Psychiatry. 2014;19(12):1252-7. doi:10.1038/mp.2014.93

Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. American Journal of Psychiatry. 2010;167(3):261-80. doi:10.1176/appi.ajp.2009.09030361

Ancona A, Petito C, Iavarone I, et al. The gut-brain axis in irritable bowel syndrome and inflammatory bowel disease. Digestive and Liver Disease. 2021;53(3):298-305. doi:10.1016/j.dld.2020.11.026

Severance EG, Alaedini A, Yang S, et al. Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophrenia Research. 2012;138(1):48-53. doi:10.1016/j.schres.2012.02.025

Carding S, Verbeke K, Vipond DT, et al. Dysbiosis of the gut microbiota in disease. Microbial ecology in health and disease. 2015;26(1):26191. doi: 10.3402/mehd.v26.26191

Camara RJ, Ziegler R, Begre S, et al. The role of psychological stress in inflammatory bowel disease: quality assessment of methods of 18 prospective studies and suggestions for future research. Digestion. 2009;80(2):129-39. doi:10.1159/000226087

Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54(10):1481-91. doi:10.1136/gut.2005.064261

Allen AP, Dinan TG, Clarke G, et al. A psychology of the human brain-gut-microbiome axis. Social Personality Psychology Compass. 2017;11(4):e12309. doi:10.1111/spc3.12309

Oğuzcan K, DÖNMEZ N. İkinci beyin: Bağırsak. Atatürk Üniversitesi Veteriner Bilimleri Dergisi. 2020;15(2):187-95. doi:10.17094/ataunivbd.701620

Romijn AR, Rucklidge JJ, Kuijer RG, et al. A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. Australian and New Zealand Journal of Psychiatry. 2017;51(8):810-21. doi:10.1177/0004867416686694

Liu X, Vigorito M, Huang W, et al. The Impact of Alcohol-Induced Dysbiosis on Diseases and Disorders of the Central Nervous System. Journal of Neuroimmune Pharmacology. 2022;17(1-2):131-51. doi:10.1007/s11481-021-10033-4

Engen PA, Green SJ, Voigt RM, et al. The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota. Alcohol Research: Current Reviews. 2015;37(2):223-36

Leclercq S, Matamoros S, Cani PD, et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proceedings of the National Academy of Sciences of the United States of America .2014;111(42):E4485-93. doi:10.1073/pnas.1415174111

Sugeçti S. , Büyükgüzel E. , Büyükgüzel K. Barsak Mikrobiyotasının Nörodejeneratif Hastalıklar Üzerindeki Patofizyolojik Rolü. Journal of Immunology and Clinical Microbiology. 2019; 4(4): 152-157.

Zhuang ZQ, Shen LL, Li WW, et al. Gut Microbiota is Altered in Patients with Alzheimer's Disease. Journal of Alzheimer's disease. 2018;63(4):1337-46. doi:10.3233/JAD-180176

Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nature Reviews Neurology. 2011;7(3):137-52. doi:10.1038/nrneurol.2011.2

Freeman LR, Haley-Zitlin V, Rosenberger DS, et al. Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms. Nutritional Neuroscience. 2014;17(6):241-51. doi:10.1179/1476830513Y.0000000092

Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nature reviews Disease primers. 2017;3(1):1-21. doi: 10.1038/nrdp.2017.13

Alagöz AN. Mikrobiyota ve nörodejenerasyon. Journal of Biotechnology and Strategic Health Research. 2017;1:115-22

GÜNAL Dİ. Parkinson Hastalığından Korunmak Mümkün mü? Acta Neuropathol. 2007;113:421-9. doi: 10.5606/phhb.dergisi.2017.01

Hill‐Burns EM, Debelius JW, Morton JT, et al. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Movement Disorders. 2017;32(5):739-49. doi: 10.1002/mds.26942

Doenyas C. Gut Microbiota as the Mechanism Enabling the Effects of Environment and Diet on Autism. Journal of Turkish Society of Microbiology. 2019;49(3):113-7. doi:10.5222/TMCD.2019.113

Chaidez V, Hansen RL, Hertz-Picciotto I. Gastrointestinal problems in children with autism, developmental delays or typical development. Journal of Autism and Developmental Disorders. 2014;44(5):1117-27. doi:10.1007/s10803-013-1973-x

Ding H, Yi X, Zhang X, et al. Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders. Frontiers in Cellular and Infection Microbiology. 2021;11:572752. doi:10.3389/fcimb.2021.572752

Borre YE, O'Keeffe GW, Clarke G, et al. Microbiota and neurodevelopmental windows: implications for brain disorders.

Trends Molecular Medicine. 2014;20(9):509-18. doi:10.1016/j.molmed.2014.05.002

Ersoz Alan B, Gulerman F. The Role of Gut Microbiota in Autism Spectrum Disorder. Turk Psikiyatri Dergisi. 2019;30(3):210-9

Güller N, Değerli S, Amine S, et al. Otizm spektrum bozukluğunda bağırsak-beyin aksı, diyet yaklaşımları ve probiyotik tedavisi. Haliç Üniversitesi Sağlık Bilimleri Dergisi. 2020;3(2):69-82

Diaz Heijtz R, Gressens P, Swann JR. Targeting microbial metabolites to treat autism. Nature Medicine. 2022;28(3):448-50. doi:10.1038/s41591-022-01711-8

Delzenne NM, Neyrinck AM, Backhed F, et al. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nature Reviews Endocrinology. 2011;7(11):639-46. doi:10.1038/nrendo.2011.126

Durmaz B. Bağırsak Mikrobiyotası ve Obezite İlişkisi. Türk Hijyen ve Deneysel Biyoloji Dergisi. 2019;76(3):353-60. doi: 10.5505/TurkHijyen.2019.50375

Lee K, Paek K, Lee HY, et al. Antiobesity effect of trans-10,cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. Journal of Applied Microbiology. 2007;103(4):1140-6. doi:10.1111/j.1365-2672.2007.03336.x

Organization WHO. Global report on diabetes: World Health Organization; 2016.

Kamarlı Altun H. , Akal Yıldız E. Relationship Between Prebiotics-Probiotics and Diabetes Mellitus. Turkish Journal of Life Sciences. 2017; 2(1): 149-156.

Grasset E, Puel A, Charpentier J, et al. A specific gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance through an enteric NO-dependent and gut-brain axis mechanism. Cell metabolism. 2017;25(5):1075-90. e5. doi: 10.1016/j.cmet.2017.04.013

Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, et al. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012;28(5):539-43.doi:10.1016/j.nut.2011.08.013

Tonucci LB, Olbrich Dos Santos KM, Licursi de Oliveira L, et al. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clinical Nutrition. 2017;36(1):85-92. doi:10.1016/j.clnu.2015.11.011

Thomas H, Diamond J, Vieco A, et al. Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control. Global Heart. 2018;13(3):143-63. doi:10.1016/j.gheart.2018.09.511

McGuire S. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. Washington, DC: US Departments of Agriculture and Health and Human Services, 2015. Advances in Nutrition. 2016;7(1):202-4. doi:10.3945/an.115.011684

Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-Diaz J, et al. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases. Nutrients. 2020;12(3):605. doi:10.3390/nu12030605

Cui X, Ye L, Li J, et al. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients. Scientific Reports. 2018;8(1):635. doi:10.1038/s41598-017-18756-2

Liu Z, Li J, Liu H, et al. The intestinal microbiota associated with cardiac valve calcification differs from that of coronary artery disease. Atherosclerosis.2019;284:121-8. doi10.1016/j.atherosclerosis2018.11.038

Ou Y, Zhang C, Yao M, et al. Gut Flora: Novel Therapeutic Target of Chinese Medicine for the Treatment of Cardiovascular Diseases. Evidence-based Complementary and Alternative Medicine 2019;2019:3719596. doi:10.1155/2019/3719596

He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Bioscience. 2017;7(1):54. doi:10.1186/s13578-017-0183-1

Jandhyala SM, Talukdar R, Subramanyam C, et al. Role of the normal gut microbiota. World Journal of Gastroenterology. 2015;21(29):8787-803. doi:10.3748/wjg.v21.i29.8787

Yang T, Santisteban MM, Rodriguez V, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331-40. doi:10.1161/HYPERTENSIONAHA.115.05315

Brown A. Goldsworthy SM, Barnes AA, Eilert MM, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. Journal of Biological Chemistry. 2003;278:11312-9. doi: 10.1074/jbc.M211609200

Koren O, Spor A, Felin J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proceedings of the National Academy of Sciences. 2011;108 Suppl 1(Suppl 1):4592-8. doi:10.1073/pnas.1011383107

Karlsson FH, Fak F, Nookaew I, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nature Communications. 2012;3(1):1245. doi:10.1038/ncomms2266

Rodes L, Khan A, Paul A, et al. Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. Journal of Microbiology and Biotechnology. 2013;23(4):518-26. doi:10.4014/jmb.1205.05018

Liu Y, Dai M. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis. Mediators of Inflammation. 2020;2020:4634172. doi:10.1155/2020/4634172

Zeren R. Yetişkin Bireylerin Probiyotik Besinler Hakkında Bilgi Düzeyi ve Tüketim Durumlarının Belirlenmesi [yüksek lisans tezi]. İstanbul: Beslenme ve Diyetetik Bölümü, Haliç Üniversitesi Sağlık Bilimleri Enstitüsü; 2015.

Han P, Gu J-Q, Li L-S, et al. The Association Between Intestinal Bacteria and Allergic Diseases—Cause or Consequence? Frontiers in Cellular and Infection Microbiology. 2021:284. doi: 10.3389/fcimb.2021.650893

Brennan CA, Garrett WS. Gut Microbiota, Inflammation, and Colorectal Cancer. Annual Review of Microbiology. 2016;70:395-411. doi:10.1146/annurev-micro-102215-095513

Hirsch F, Scagliotti G, Mulshine J, et al. Lung cancer: current therapies and new targeted treatments, Lancet. 2017;389:299-311 doi: 10.1016/S0140-6736(16)30958-8

Hu B, Elinav E, Huber S, et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proceedings of the National Academy of Sciences. 2013;110(24):9862-7. doi:10.1073/pnas.1307575110

Schwabe RF, Jobin C. The microbiome and cancer. Nature Reviews Cancer. 2013;13(11):800-12. doi:10.1038/nrc3610

Tözün N, Vardareli E. Gut Microbiome and Gastrointestinal Cancer: Les liaisons Dangereuses. Journal of Clinical Gastroenterology. 2016;50 S191-S196, doi: 10.1097/MCG.0000000000000714

Meng C, Bai C, Brown TD, et al. Human Gut Microbiota and Gastrointestinal Cancer. Genomics Proteomics Bioinformatics. 2018;16(1):33-49. doi:10.1016/j.gpb.2017.06.002

Malatji BG, Mason S, Mienie LJ, et al. The GC-MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology. Metabolomics. 2019;15(4):54. doi:10.1007/s11306-019-1513-6

Albayrak B, Süsgün S, Küçükakkaş O, et al. Investigating of Relation Between Fibromyalgia Syndrome and Intestinal Microbiota. Mikrobiyoloji Bülteni. 2021;55(2). doi: 10.5578/mb.20219903.

Avan T. İnflamatuvar bağırsak hastalığı ve mikrobiyota ilişkisi [Tıpta Uzmanlık Tezi].Samsun: Ondokuz Mayıs Üniversitesi / Tıp Fakültesi / Tıbbi Mikrobiyoloji Ana Bilim Dalı Sağlık Bilimleri Enstitüsü; 2020.

Beğenik, M. İnflamatuvar bağırsak hastalığı olan ergenlerde hastalık aktivitesi, depresyon ve yaşam kalitesi ilişkisi. (Yayınlanmamış uzmanlık tezi). İstanbul: İstanbul Medipol Üniversitesi Tıp Fakültesi; 2020

Eminler AT, Toka B, Uslan Mİ. İnflamatuar Barsak Hastalığı Ve Barsak Mikrobiyotası. Journal of Biotechnology and Strategic Health Research. 2017;1:81-5

Karacaer C , Varım C , Toka B , et al. Bağırsak Mikrobiyatası, Probiyotikler ve İrritable Bağırsak Sendromu(İBS). Journal of Human Rhythm. 2017; 3(3): 120-125.

Turgay N, Zorbozan U. Disbiyozis ve Gastrointestinal Sistem.Yılmaz Ö (ed.) Mikrobiyota İçimizdeki Evren içinde.İzmir: Ege Üniversitesi Basım ve Yayınevi; 2020. 65-91

Can G, Yılmaz B. İrritabl barsak sendromunun tanı ve tedavisinde yaklaşımlar. Güncel Gastroenteroloji. 2015;19(3):171-81

Uygun A. Fekal Mikrobiyota Transplantasyonu (FMT). Journal of Biotechnology and Strategic Health Research. 2017;1:132-40